摘要
目的探讨利凡诺分别联合米非司酮和生化汤在中期妊娠引产应用中的临床效果。方法2009年1月～2011年7月300例来我院中期妊娠引产的患者随机分成米非司酮组150例和生化汤组150例,两组均应用利凡诺中期引产,米非司酮组术前1 d口服米非司酮,生化汤组在注射当天同时口服生化汤,每日一剂,对比观察两组患者引产成功率、引产时间、阴道流血量、胎盘胎膜残留情况及并发症情况。结果两组引产成功率相比并统计学意义(P>0.05);米非司酮组胎儿引出时间及总产程时间明显短于生化汤组,阴道流血量也少于生化汤组(P<0.05);但米非司酮组胎盘胎膜残留情况及产后出血发生率明显高于生化汤组(P<0.05)。结论米非司酮和生化汤在联合利凡诺中期妊娠引产应用中各有利弊,适用不同体质患者。
Objective To compare the effectiveness and safety of mifepristone and decoction shenghua on mid-trimester abortion. Methods A total of 300 cases with pregnancy that voluntarily required induced abortion were divided into mifepristone group and shenghua group. The mifepristone group was given Ethacridine Lactate combined with mifepristone while the shenghua group combined with decoction shenghua. Results The success rate of abortion had no significant dif- ference（P 〈 0.05）; and embryo excluding time in the mifepristone group was shorter than the shenghua group, vaginal bleed- ing and complications were less than the shenghua group, but the incidence of placenta remanant and the rate of postpar turn bleeding were higher than the shenghua group （P〈 0.05）. Conclusion Mifepristone and decoction shenghua on mid- trimester abortion has its own advantages.
出处
《中国现代医生》
2012年第15期66-67,共2页
China Modern Doctor
关键词
米非司酮
生化汤
中期引产
Mifepristone
Decoction shenghua
Abortion
